These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1455 related items for PubMed ID: 8763848
21. Assessment of micronucleus induction in SCCVII cells treated with bioreductive agents, WIN 59075 (SR 4233) and mitomycin C, under aerobic and hypoxic conditions. Shibata T, Shibamoto Y, Sasai K, Oya N, Takagi T, Murata R, Abe M. Mutat Res; 1995 Apr; 342(3-4):171-7. PubMed ID: 7715618 [Abstract] [Full Text] [Related]
23. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging. Bains LJ, Baker JH, Kyle AH, Minchinton AI, Reinsberg SA. Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):957-65. PubMed ID: 19480975 [Abstract] [Full Text] [Related]
24. Physiologic and cytotoxic effects of tirapazamine in tumor-bearing mice. Durand RE, Olive PL. Radiat Oncol Investig; 1997 Jul 01; 5(5):213-9. PubMed ID: 9372543 [Abstract] [Full Text] [Related]
25. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine. Hay MP, Gamage SA, Kovacs MS, Pruijn FB, Anderson RF, Patterson AV, Wilson WR, Brown JM, Denny WA. J Med Chem; 2003 Jan 02; 46(1):169-82. PubMed ID: 12502371 [Abstract] [Full Text] [Related]
26. Dual action of tirapazamine in the induction of DNA strand breaks. Jones GD, Weinfeld M. Cancer Res; 1996 Apr 01; 56(7):1584-90. PubMed ID: 8603406 [Abstract] [Full Text] [Related]
27. Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Shibamoto Y, Streffer C, Fuhrmann C, Budach V. Radiat Res; 1991 Dec 01; 128(3):293-300. PubMed ID: 1961926 [Abstract] [Full Text] [Related]
28. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status. Masunaga S, Ono K, Takahashi A, Ohnishi K, Ohnishi T, Suzuki M, Nagata K, Kinashi Y, Nagasawa H, Uto Y, Hori H. Cancer Sci; 2003 Jan 01; 94(1):125-33. PubMed ID: 12708486 [Abstract] [Full Text] [Related]
29. Effects of tirapazamine on experimental colorectal liver metastases after radiofrequency ablation. Govaert KM, Nijkamp MW, Emmink BL, Steller EJ, Minchinton AI, Kranenburg O, Borel Rinkes IH. Br J Surg; 2012 Apr 01; 99(4):567-75. PubMed ID: 22331808 [Abstract] [Full Text] [Related]
30. Estimation of the initial slope of the cell survival curve after irradiation from micronucleus frequency in cytokinesis-blocked cells. Ono K, Masunaga S, Akaboshi M, Akuta K. Radiat Res; 1994 Apr 01; 138(1 Suppl):S101-4. PubMed ID: 8146309 [Abstract] [Full Text] [Related]
31. Does AK-2123 (Senazole) have sensitizing effects on radiation, cisplatin and hyperthermia under aerobic conditions in vitro? Mitsuhashi N, Sakurai H, Takahashi T, Akimoto T, Higuchi K, Matsumoto H, Ebara T, Nozaki M, Niibe H. Anticancer Res; 1998 Apr 01; 18(5A):3463-7. PubMed ID: 9858925 [Abstract] [Full Text] [Related]
32. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells. Masunaga SI, Ono K, Suzuki M, Kinashi Y, Takagaki M, Hori H, Kasai S, Nagasawa H, Uto Y. Jpn J Cancer Res; 2000 May 01; 91(5):566-72. PubMed ID: 10835503 [Abstract] [Full Text] [Related]
33. Optical isomers of a new 2-nitroimidazole nucleoside analog (PR-350 series): radiosensitization efficiency and toxicity. Oya N, Shibamoto Y, Sasai K, Shibata T, Murata R, Takagi T, Iwai H, Suzuki T, Abe M. Int J Radiat Oncol Biol Phys; 1995 Aug 30; 33(1):119-27. PubMed ID: 7642409 [Abstract] [Full Text] [Related]
34. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells. Masunaga S, Ono K, Nishimura Y, Kanamori S, Saga T, Suzuki M, Kinashi Y, Takagaki M, Kasai S, Nagasawa H, Uto Y, Hori H. Int J Radiat Oncol Biol Phys; 2000 Jun 01; 47(3):799-807. PubMed ID: 10837967 [Abstract] [Full Text] [Related]
35. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells. Xu P, Huang JM, Ren Y, Zha X, Deng BF, Wu JH, Lang JY. Chin J Cancer; 2010 Feb 01; 29(2):126-30. PubMed ID: 20109337 [Abstract] [Full Text] [Related]
36. Nitroimidazole-based bioreductive compounds bearing a quinazoline or a naphthyridine chromophore. Papadopoulou MV, Bloomer WD. Anticancer Drugs; 2009 Jul 01; 20(6):493-502. PubMed ID: 19430289 [Abstract] [Full Text] [Related]
37. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine. Wouters BG, Delahoussaye YM, Evans JW, Birrell GW, Dorie MJ, Wang J, MacDermed D, Chiu RK, Brown JM. Cancer Res; 2001 Jan 01; 61(1):145-52. PubMed ID: 11196153 [Abstract] [Full Text] [Related]
38. Measurement of micronuclei by cytokinesis-block method in human, cattle, goat, pig, rabbit, chicken and fish peripheral blood lymphocytes irradiated in vitro with gamma radiation. Kim SR, Kim TH, Ryu SY, Lee HJ, Oh H, Jo SK, Oh KS, Park IC, Kim JC, Kang CM, Kim SH. In Vivo; 2003 Jan 01; 17(5):433-8. PubMed ID: 14598606 [Abstract] [Full Text] [Related]
39. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc. Kriehuber R, Kadenbach K, Schultz F, Weiss DG. Int J Radiat Biol; 2004 Jan 01; 80(11-12):875-80. PubMed ID: 15764396 [Abstract] [Full Text] [Related]
40. Radical properties governing the hypoxia-selective cytotoxicity of antitumor 3-amino-1,2,4-benzotriazine 1,4-dioxides. Anderson RF, Shinde SS, Hay MP, Gamage SA, Denny WA. Org Biomol Chem; 2005 Jun 07; 3(11):2167-74. PubMed ID: 15917906 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]